Entecavir (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the Entecavir drug offered from Zydus Pharmaceuticals (USA) Inc.. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
| NON-PROPRIETARY NAME: | Entecavir |
| SUBSTANCE NAME: | ENTECAVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-10 |
| END MARKETING DATE: | 0000-00-00 |
Entecavir HUMAN PRESCRIPTION DRUG Details:
| Item Description | Entecavir from Zydus Pharmaceuticals (USA) Inc. |
| LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2017-08-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68382-920_23fe4300-bf01-403b-8b1c-ff877aba62be |
| PRODUCT NDC: | 68382-920 |
| APPLICATION NUMBER: | ANDA206745 |
Other ENTECAVIR Pharmaceutical Manufacturers / Labelers:
